NOVO — Februar 2026
-
ResearchPulse
@ResearchPulse1
·Wegovy pill IQVIA data up with 17.2% over last week……
Wegovy pen + pill up with about 3% over last week.
Zepbound down about 9% vs last week.
Wegovy keeps gaining back market share
Last week included Presidents Day. A holiday. https://x.com/ResearchPulse1/status/2027378898938318870
-
THE @US_FDA
OFFICIALLY REMOVES SUICIDAL BEHAVIOR/IDEATION AND DEPRESSION FROM LIST OF POSSIBLE SIDE EFFECTS FROM ENTIRE CLASS OF OBESITY GLP-1 MEDICATIONS. -
On the pen om lovgivning omkring compounding https://www.youtube.com/watch?v=y9TKVjmIrf8
-
I denne episode af The Downsized gennemgår Christopher Durham Novo Nordisks seneste REDEFINE 4-studieresultater for CagriSema - en næste generations fedmebehandling, der gav et gennemsnitligt vægttab på 23 % over 84 uger.
Denne video udforsker, hvad resultaterne rent faktisk viste, hvorfor de er vigtige, og hvordan de afspejler et bredere skift i fedmebehandling. https://proinvestor.com/boards/131354/
-
FDA approves Novo Nordisk's Sogroya
as the first and only once-weekly, long-acting growth hormone for three additional pediatric indicationsFDA approves Novo Nordisk's Sogroya as the first and only once-weekly, long-acting growth hormone for three additional pediatric indications https://www.novonordisk-us.com/media/news-archive/news-details.html?id=916507&utm_medium=organic&utm_source=twitter&utm_campaign=2026-media-release&utm_content=nni-pediatric-growth-sci_inn -
Data fra Wegovy Pill Trx viser: 36,1% af patienterne havde aldrig taget GLP-1-medicin før. 21,1% var skiftet fra en injicerbar version til Wegovy-pille, 15,8% var skiftet fra Eli Lillys injicerbare Zepbound.
https://www.biospace.com/business/oral-wegovy-brings-in-thousands-of-new-glp-1-patients -
Lillys Orfoglipron 10. april? https://proinvestor.com/boards/131357
-
Walgreens debuts virtual weight management clinic with access to GLP-1 meds https://www.fiercehealthcare.com/health-tech/walgreens-debuts-virtual-weight-management-clinic-access-glp-1-meds?_gl=1*1t145on*_gcl_au*MTE2MTI4NzAyLjE3NzE5NjE1NTM.*_ga*MTAzNTI1NzA2NC4xNzcxOTYxNTQz*_ga_KG49J84SR4*czE3NzIyNjE1MjYkbzckZzEkdDE3NzIyNjE1MzQkajUyJGwwJGgw
-
Seeking Alfa artikel - l https://seekingalpha.com/article/4876511-eli-lilly-vs-novo-nordisk-the-valuation-gap-is-unreasonable
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind